Back
53
38
Day Range
$35.26
$36.28
52-Week Range
$21.38
$46.00
Volume
60,957
50D / 200D Avg
$40.14
/
$37.52
Prev Close
$35.71
Price History
Financial Trends
Peer Comparison
vs Consumer Cyclical sector median (610 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 10.1 | 11.1 |
| P/B | 1.2 | 1.4 |
| ROE % | 12.2 | 10.7 |
| Net Margin % | 4.4 | 5.1 |
| Rev Growth 5Y % | 8.4 | 8.1 |
| D/E | 1.0 | 0.8 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$0.00
$0.00 – $0.00
|
2.2 B | 0 |
| FY2028 |
$5.02
$4.95 – $5.08
|
2 B | 1 |
| FY2027 |
$4.92
$4.60 – $5.24
|
1.9 B | 2 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 |
Sills Eric
CEO & President
|
grant | 6,048 | — | — |
| Feb 24, 2026 |
Iles Nathan R.
Chief Financial Officer
|
grant | 7,527 | — | — |
| Feb 24, 2026 |
BURKE JAMES J
Chief Operating Officer
|
grant | 579 | — | — |
| Feb 24, 2026 |
Ringwood Victoria T.
CHRO
|
grant | 3,474 | — | — |
| Nov 10, 2025 |
BURKE JAMES J
Chief Operating Officer
|
grant | 1,014 | — | — |
| Oct 29, 2025 |
Nicholas Ray
CIO & VP IT
|
grant | 3,268 | — | — |
| Oct 29, 2025 |
Iles Nathan R.
Chief Financial Officer
|
grant | 8,795 | — | — |
| Oct 29, 2025 |
BURKE JAMES J
Chief Operating Officer
|
grant | 2,011 | — | — |
| Oct 29, 2025 |
Broccole Carmine Joseph
CLO & Secretary
|
grant | 2,513 | — | — |
| Jul 3, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
buy | 4,000 | — | — |
| Jul 3, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
sell | 19,690 | $12.82 | — |
| Jul 2, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
sell | 15,598 | $12.54 | $195,546 |
| Jul 1, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
other | 61,928 | — | — |
| Jun 3, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
buy | 4,000 | — | — |
| Jun 3, 2025 |
Pantelick Steven
CHIEF FINANCIAL OFFICER
|
sell | 8,000 | $12.07 | — |
| May 15, 2025 |
Lieberman Pamela Forbes
Director
|
grant | 4,230 | — | — |
| May 15, 2025 |
McDonnell Joseph W.
Director
|
grant | 4,230 | — | — |
| May 15, 2025 |
McClymont Patrick
Director
|
grant | 4,230 | — | — |
| May 15, 2025 |
Puryear Pamela
Director
|
grant | 4,230 | — | — |
| May 15, 2025 |
Capparelli Alejandro C.
Director
|
grant | 4,230 | — | — |
Key Takeaways
Revenue grew 8.37% annually over 5 years — modest growth
Earnings grew 47.37% over the past year
ROE of 12.16% — decent returns on equity
Generating 18.72M in free cash flow
P/E of 10.12 — trading at a low valuation
PEG of 0.22 suggests growth is underpriced
Growth
Revenue Growth (5Y)
8.37%
Revenue (1Y)22.36%
Earnings (1Y)47.37%
FCF Growth (3Y)-59.77%
Quality
Return on Equity
12.16%
ROIC10.11%
Net Margin4.41%
Op. Margin10.28%
Safety
Debt / Equity
1.00
Current Ratio2.13
Interest Coverage5.60
Valuation
P/E Ratio
10.12
P/B Ratio1.17
EV/EBITDA7.66
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22.36% | Revenue Growth (3Y) | 14.83% |
| Earnings Growth (1Y) | 47.37% | Earnings Growth (3Y) | 11.88% |
| Revenue Growth (5Y) | 8.37% | Earnings Growth (5Y) | -3.43% |
| Profitability | |||
| Revenue (TTM) | 1.79B | Net Income (TTM) | 79.03M |
| ROE | 12.16% | ROA | 3.96% |
| Gross Margin | 30.20% | Operating Margin | 10.28% |
| Net Margin | 4.41% | Free Cash Flow (TTM) | 18.72M |
| ROIC | 10.11% | FCF Growth (3Y) | -59.77% |
| Safety | |||
| Debt / Equity | 1.00 | Current Ratio | 2.13 |
| Interest Coverage | 5.60 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 10.12 | P/B Ratio | 1.17 |
| P/S Ratio | 0.45 | PEG Ratio | 0.22 |
| EV/EBITDA | 7.66 | Dividend Yield | 0.03% |
| Market Cap | 799.47M | Enterprise Value | 1.41B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.79B | 1.46B | 1.36B | 1.37B | 1.30B |
| Net Income | 79.03M | 53.63M | 63.14M | 73.04M | 90.89M |
| EPS (Diluted) | 3.52 | 2.41 | 2.85 | 3.30 | 4.02 |
| Gross Profit | 541.01M | 413.32M | 379.53M | 373.24M | 367.93M |
| Operating Income | 184.05M | 139.22M | 141.24M | 137.91M | 140.88M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.00B | 1.81B | 1.29B | 1.25B | 1.20B |
| Total Liabilities | 1.30B | 1.18B | 642.17M | 633.89M | 585.33M |
| Shareholders' Equity | 683.70M | 615.75M | 635.06M | 610.02M | 601.58M |
| Total Debt | 682.10M | 660.53M | 245.19M | 280.33M | 159.64M |
| Cash & Equivalents | 72.03M | 44.43M | 32.53M | 21.15M | 21.76M |
| Current Assets | 1.05B | 921.92M | 744.22M | 762.44M | 711.21M |
| Current Liabilities | 493.31M | 436.47M | 304.26M | 323.13M | 476.37M |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#160 of 618
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#259 of 332
Recent Activity
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026